Shiwei Deng

GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies

Marit Holden, Shiwei Deng, Leszek Wojnowski et al. · Bioinformatics · 2008 · 186 citations · Full text

Life Sciences, Bioinformatics, Genetics +15

Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms

Shiwei Deng, Tiandong Yan, Cathleen Jendrny et al. · BMC Cancer · 2014 · 174 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Association of NADPH Oxidase Polymorphisms with Anthracycline-Induced Cardiotoxicity in the RICOVER-60 Trial of Patients with Aggressive CD20 ⁺ B-Cell Lymphoma

Annegret Reichwagen, Marita Ziepert, Markus Kreuz et al. · Pharmacogenomics · 2015 · 51 citations

Medicine, Immunology, Oncology +17

Topoisomerase IIα-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin

Tiandong Yan, Shiwei Deng, Annegret Metzger et al. · Molecular Cancer Therapeutics · 2009 · 50 citations

Medicine, Oncology, Pharmacology +17

The catalytic topoisomerase <scp>II</scp> inhibitor dexrazoxane induces <scp>DNA</scp> breaks, <scp>ATF</scp>3 and the <scp>DNA</scp> damage response in cancer cells

Shiwei Deng, Tiandong Yan, Teodora Nikolova et al. · British Journal of Pharmacology · 2014 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +17